CBD drug trial at UMMC delivers promising results; gets one-year extension – WLBT

The clinically tested investigational drug product is an oral cannabidiol, CBD for short, derived from marijuana grown at the University of Mississippi School of Pharmacy’s National Center for Natural Products Research. To conduct the trial, required approvals were obtained in 2018 from the Drug Enforcement Agency and the Food and Drug Administration.

Source: https://www.wlbt.com/2019/08/02/cbd-drug-trial-ummc-delivers-promising-results-gets-one-year-extension/

« »